Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...
GlobalData on MSN1d
Perspectum awarded $250k FDA grant for rare disease researchThe grant will support Perspectum’s research into the development of a novel biomarker for primary sclerosing cholangitis ...
The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the ...
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback